# Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

> **NCT07311772** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 386 (estimated)

## Conditions studied

- Nasopharyngeal Cancinoma (NPC)
- Radiation-induced Oral Mucositis

## Interventions

- **DRUG:** Houyanqing Oral Liquid
- **OTHER:** Conventional Treatment for Radiation-Induced Oral Mucositis

## Key facts

- **NCT ID:** NCT07311772
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 386 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- Fujian Cancer Hospital
- Eye & ENT Hospital of Fudan University
- Zhejiang Cancer Hospital
- West China Hospital
- Yunnan Cancer Hospital
- First Affiliated Hospital of Kunming Medical University
- The First People's Hospital of Changzhou
- Xiangya Hospital of Central South University
- Affiliated Cancer Hospital of Shantou University Medical College
- Wuzhou Red Cross Hospital
- Hunan Cancer Hospital
- Cancer Hospital of Guangxi Medical University
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Sun Yat-Sen University Cancer Center
- Cancer Hospital Chinese Academy of Medical Science
- The Fifth Affiliated Hospital, Sun Yat-sen University

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07311772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07311772, "Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07311772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*